These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10795554)
1. Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. Goebel C; Hardt P; Doppl W; Temme H; Hackstein N; Klör HU Eur Radiol; 2000; 10(4):677-80. PubMed ID: 10795554 [TBL] [Abstract][Full Text] [Related]
2. [Prospects of the use of non-ionic X-ray contrast substances during endoscopic retrograde cholangiopancreatography]. Sviridov NK; Napolov IuK Vestn Rentgenol Radiol; 2003; (6):62-3. PubMed ID: 14674360 [No Abstract] [Full Text] [Related]
3. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography. Banerjee AK; Grainger SL; Thompson RP Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293 [TBL] [Abstract][Full Text] [Related]
4. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS). Kruse A; Brock A; Rodenberg J; Nowakowska-Duawa E; Bjartveit K Eur Radiol; 1997; 7 Suppl 4():S131-4. PubMed ID: 9204355 [TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography. Jensen AR; Malchow-Møller A; Matzen P; Larsen JE; Møller F; Andersen JR; Magid E Scand J Gastroenterol; 1985 Jan; 20(1):83-6. PubMed ID: 2581308 [TBL] [Abstract][Full Text] [Related]
7. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Sand J; Nordback I Digestion; 1993; 54(2):105-11. PubMed ID: 8319838 [TBL] [Abstract][Full Text] [Related]
8. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104 [TBL] [Abstract][Full Text] [Related]
9. Frequency of common factors for post endoscopic retrograde cholangiopancreatography pancreatitis. Haqqi SA; Mansoor-ul-Haq M; Shaikh H J Coll Physicians Surg Pak; 2011 Aug; 21(8):464-7. PubMed ID: 21798131 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L; Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116 [TBL] [Abstract][Full Text] [Related]
11. [Prospects of the use of non-ionic X-ray contrast media during endoscopic retrograde cholangiopancreatography]. Sviridov NK; Napolov IuK Vestn Rentgenol Radiol; 2002; (6):62-3. PubMed ID: 12722628 [No Abstract] [Full Text] [Related]